Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.

Flanagan KC, Earls J, Hiken J, Wellinghoff RL, Ponder MM, McLeod HL, Westra WH, Vavinskaya V, Sutton L, Deichaite I, Macdonald OK, Welaya K, Wade J 3rd, Azzi G, Pippas AW, Slim J, Bank B, Sui X, Kossman SE, Shenkenberg TD, Alexander WL, Price KA, Ley J, Messina DN, Glasscock JI, Colevas AD, Cohen EEW, Adkins D, Duncavage EJ

Open source

DOI: 10.1136/jitc-2024-009573
Published: 2024 Nov 3
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2024-009573,
  title = {Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.},
  author = {Flanagan KC and Earls J and Hiken J and Wellinghoff RL and Ponder MM and McLeod HL and Westra WH and Vavinskaya V and Sutton L and Deichaite I and Macdonald OK and Welaya K and Wade J 3rd and Azzi G and Pippas AW and Slim J and Bank B and Sui X and Kossman SE and Shenkenberg TD and Alexander WL and Price KA and Ley J and Messina DN and Glasscock JI and Colevas AD and Cohen EEW and Adkins D and Duncavage EJ},
  year = {2024},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2024-009573},
  url = {https://doi.org/10.1136/jitc-2024-009573}
}

RIS

TY  - JOUR
TI  - Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
AU  - Flanagan KC
AU  - Earls J
AU  - Hiken J
AU  - Wellinghoff RL
AU  - Ponder MM
AU  - McLeod HL
AU  - Westra WH
AU  - Vavinskaya V
AU  - Sutton L
AU  - Deichaite I
AU  - Macdonald OK
AU  - Welaya K
AU  - Wade J 3rd
AU  - Azzi G
AU  - Pippas AW
AU  - Slim J
AU  - Bank B
AU  - Sui X
AU  - Kossman SE
AU  - Shenkenberg TD
AU  - Alexander WL
AU  - Price KA
AU  - Ley J
AU  - Messina DN
AU  - Glasscock JI
AU  - Colevas AD
AU  - Cohen EEW
AU  - Adkins D
AU  - Duncavage EJ
PY  - 2024
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2024-009573
UR  - https://doi.org/10.1136/jitc-2024-009573
ER  -

APA

KC, F., J, E., J, H., RL, W., MM, P., HL, M., WH, W., V, V., L, S., I, D., OK, M., K, W., 3rd, W. J., G, A., AW, P., J, S., B, B., X, S., SE, K., TD, S., WL, A., KA, P., J, L., DN, M., JI, G., AD, C., EEW, C., D, A., & EJ, D. (2024). Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2024-009573

Source records

pubmed · retrieved 2026-09-26T02:59:15.352Z